Filing Details

Accession Number:
0001140361-14-002751
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-21 16:07:05
Reporting Period:
2014-01-16
Filing Date:
2014-01-21
Accepted Time:
2014-01-21 16:07:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037760 Cepheid CPHD Laboratory Analytical Instruments (3826) 770441625
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479659 Kerry Flom C/O Cepheid
904 Caribbean Drive
Sunnyvale CA 94089
Evp, Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-01-16 8,437 $35.72 28,437 No 4 M Direct
Common Stock Disposition 2014-01-16 8,437 $49.72 20,000 No 4 S Direct
Common Stock Acquisiton 2014-01-16 7,187 $35.48 27,187 No 4 M Direct
Common Stock Disposition 2014-01-16 7,187 $49.48 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (right to buy) Disposition 2014-01-16 8,437 $0.00 8,437 $35.72
Common Stock Non-qualified Stock Option (right to buy) Disposition 2014-01-16 7,187 $0.00 7,187 $35.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,063 2019-04-24 No 4 M Direct
21,563 2020-01-02 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 11, 2013.
  2. 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.